Amyloid regulation and phase separation of a yeast prion domain
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
IISER Mohali
Abstract
Adenosine triphosphate (ATP) is the cellular energy currency that provides energy for multiple
cellular processes and drives biological machinery, including the chaperones involved in protein
quality control (PQC). Apart from its indirect roles in the PQC via operating the chaperones, recent
studies suggested the direct molecular role of ATP in protein homeostasis by controlling amyloid
formation and dissolution of preformed amyloids. Several attempts were made to understand the
chemical nature of ATP-protein interactions that govern the genesis of amyloids and their
dissolution; however, the impact of such events in the cell-to-cell amyloid transmission remains
largely uncharacterized. Here, in this in vitro study to understand the role of ATP in prion-like
amyloid colonization using the intrinsically disordered domain of a yeast prion Sup35 by utilizing
an amalgamation of biophysical and biochemical tools, we discerned that high concentrations of
ATP accelerated the amyloid aggregation with the help of magnesium. Additionally, we
recapitulated disaggregation of preformed amyloids in a wide range of ATP concentrations ranging
from nanomolar to millimolar. In addition to the kinetic alteration, the amyloids generated in the
presence of high concentrations of ATP showed remarkable compactness in the amyloid core
resulting in minimal disaggregation by ATP itself that limits the number of transmissible seeds.
Intriguingly, in low concentrations, ATP gave rise to such amyloids that showed no seeding
potential, indicating a possible alternative anti-prion strategy in this concentration regime. Our
study shed light on two distinct strategies that can restrict amyloid propagation depending on the
cellular ATP concentrations. Further, to understand the role of ATP in regulating material states
and phase transition of liquid-like droplets, we tried to standardize the protocol for liquid-liquid
phase separation of an intrinsically disordered prion domain of Sup35.